Total Reports
41
FDA CVM filings
Rabbit /
2026 FDA CVM data 41 reports on file official source
New Zealand White — FDA Adverse Event Profile
Adverse-event records and label data for New Zealand White (Rabbit), sourced from the FDA Center for Veterinary Medicine. Refreshed as new reports are filed. Cite PlainBreed when reusing this analysis.
New Zealand White (Rabbit) has 41 FDA adverse event reports on record, with 18 deaths reported (4390.0% death rate) — ranking #287 by report volume. The most frequently reported reaction is Inappetence (23 cases). The top associated drug is Imidacloprid + Moxidectin. Average age at report: 1.4 years.
Deaths Reported
18
of 41 reports
Death Rate
4390.0%
death-coded share
Avg Age at Report
1.4 yr
4.5 kg avg weight
Death-Coded Outcome Share
New Zealand White death-coded reports 100.0%
Database median
4390.0% of 41 reports involved a death outcome. Read alongside breed popularity, veterinary access, and owner awareness — these shape how many events ever reach the FDA. The 12% comparison line is the rough cross-breed median in the FDA CVM database; values above suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 4.5 kg (9.9 lbs)
Top Reported Reactions
Inappetence 23
Weight loss 23
Death 9
Stillbirth 6
Death by euthanasia 4
Impaired hearing 3
Otitis externa 3
Internal ear disorder 3
External ear disorder NOS 3
Injection site pruritus 2
Excoriation 2
Behavioural disorder NOS 2
Head tilt - neurological disorder 2
Otitis interna 2
Vestibular disorder NOS 2
Most Referenced Drugs
Imidacloprid + Moxidectin 26
Enrofloxacin 5
Isoflurane 4
Enrofloxacin + Silver Sulfadiazine 3
Saline 3
Buprenorphine 3
Midazolam 3
Pimobendan 2
Robenacoxib 2
Panacur 1
Milbemycin Oxime Solution 1
Ketamine Hcl 1
Xylazine Hydrochloride 1
Maropitant Citrate 1
Ketamine Hydrochloride 1
Outcome Breakdown
Outcome Unknown
18 (43.9%)
Died
11 (26.8%)
Euthanized
7 (17.1%)
Recovered/Normal
4 (9.8%)
Ongoing
1 (2.4%)
Gender Distribution
Female 20 (48.8%)
Male 10 (24.4%)
Mixed 7 (17.1%)
Unknown 4 (9.8%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2011 | 2 | |
| 2012 | 2 | |
| 2013 | 26 | |
| 2015 | 1 | |
| 2016 | 2 | |
| 2018 | 3 | |
| 2020 | 1 | |
| 2022 | 3 | |
| 2025 | 1 | |
New Zealand White Pet Health Insights
Across the FDA Center for Veterinary Medicine adverse event database, New Zealand White accounts for 41 submitted reports and currently ranks #287 by report volume within the rabbit population. Of those reports, 18 involved a death outcome — a 4390.0% case-fatality figure calculated directly from the underlying FDA records rather than from external mortality studies. The mean age at time of reporting is 1.4 years, with an average recorded body weight of 4.5 kg (9.9 lbs). These figures reflect the voluntary reporting pool only and should be read alongside breed popularity, veterinary access, and owner awareness — all of which shape how many events ever reach the FDA.
The most frequently reported clinical signs for New Zealand White are Inappetence (23 reports), Weight loss (23 reports), Death (9 reports), together capturing a substantial share of the top-reaction traffic seen in this breed's record. On the product side, Imidacloprid + Moxidectin appears in 26 reports and is the single most-referenced drug, followed by Enrofloxacin (5) and Isoflurane (4). Counts like these surface which therapeutic classes dominate the reporting stream — useful context when comparing reactions across breeds of the same rabbit species.
Outcome coding on the 41 reports with a recorded status is dominated by Outcome Unknown (43.9% of coded outcomes). Annual submission volume ranges from 2,011 to 2,025 reports across the 9 years on file, indicating the reporting trend is shaped as much by awareness cycles as by underlying clinical events. Because FDA adverse event reports describe correlation rather than causation, these numbers are most useful as a signal of where to ask further questions with a veterinarian — not as a standalone risk score for any individual rabbit.
Understanding New Zealand White Adverse Event Data
New Zealand White has 41 adverse event reports on file. Lower report volumes may reflect a less common breed, lower reporting rates, or genuinely fewer adverse events.
The 4390.0% death rate is above average, though this statistic should be interpreted cautiously. Death reports may be overrepresented because serious outcomes are more likely to be reported than mild reactions.
The most frequently referenced drug in adverse reports is Imidacloprid + Moxidectin, appearing in 26 reports. This may indicate widespread use of the medication rather than a specific safety concern for New Zealand White.
Other Rabbit Breeds
Frequently Asked Questions
How many FDA adverse event reports involve New Zealand White? ▼
There are 41 adverse event reports involving New Zealand White in the FDA database, with 18 reports involving death (4390.0% death rate). New Zealand White ranks #287 by report volume.
What are the most common adverse reactions reported for New Zealand White? ▼
The most commonly reported adverse reactions for New Zealand White are Inappetence (23 reports), Weight loss (23 reports), Death (9 reports), Stillbirth (6 reports), Death by euthanasia (4 reports).
What drugs are most frequently associated with New Zealand White adverse events? ▼
The drugs most frequently referenced in New Zealand White adverse event reports are Imidacloprid + Moxidectin (26 reports), Enrofloxacin (5 reports), Isoflurane (4 reports), Enrofloxacin + Silver Sulfadiazine (3 reports), Saline (3 reports).
What is the average age of New Zealand White in adverse event reports? ▼
The average age of New Zealand White at the time of adverse event reports is 1.4 years, with an average weight of 4.5 kg (9.9 lbs).
Does a high number of adverse event reports mean New Zealand White is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this New Zealand White safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Guides & Resources
Understanding Adverse Events
What FDA reports are and how they are collected
Breed-Specific Risks
Why some breeds appear in more adverse event reports
Pet Medication Safety
Evaluating medication risks using FDA data
Most Reported Medications
Drugs that appear most in adverse event reports
How FDA CVM Tracks Events
The reporting process and database limitations
Related Data Sources
Data Sources & Methodology
Adverse event data sourced from the FDA Center for Veterinary Medicine via the openFDA Animal & Veterinary Adverse Events API. Reports are voluntarily submitted by pet owners, veterinarians, and product manufacturers.
New Zealand White ranks #287 by total report volume. Death rate (4390.0%) reflects the proportion of reports involving death and should not be interpreted as a breed-specific mortality rate. Reporting biases, breed popularity, and veterinary access all influence report counts.
Read our methodology — how this data is sourced, computed, and verified.
Related
Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial